RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis

Cancer Cell

Volumn 28, Issue 2, 2015, Pages 253-269

  Strauss, Laura ^a   Sangaletti, Sabina ^d   Consonni, Francesca Maria ^b   Szebeni, Gabor ^a   Morlacchi, Sara ^a   Totaro, Maria Grazia ^a   Porta, Chiara ^b   Anselmo, Achille ^a   Tartari, Silvia ^a   Doni, Andrea ^a   Zitelli, Francesco ^b   Tripodo, Claudio ^c   Colombo, Mario P ^d   Sica, Antonio ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C5A; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; PROTEIN BCL 3; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SUPPRESSOR OF CYTOKINE SIGNALING 3; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER INFILTRATION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; FEMALE; GENETIC TRANSCRIPTION; GRANULOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; TH17 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; UPREGULATION; 129 MOUSE; ANIMAL; APOPTOSIS; C57BL MOUSE; CONFOCAL MICROSCOPY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MONOCYTES; MYELOID CELLS; MYELOPOIESIS; NEOPLASMS, EXPERIMENTAL; NEUTROPHILS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR BURDEN;

EID: 84939420392     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.07.006     Document Type: Article

References (56)

1. Akagi T., Saitoh T., O'Kelly J., Akira S., Gombart A.F., Koeffler H.P. Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells. Blood 2008, 111:2999-3004.
2. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
3. Chow A., Lucas D., Hidalgo A., Méndez-Ferrer S., Hashimoto D., Scheiermann C., Battista M., Leboeuf M., Prophete C., van Rooijen N., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 2011, 208:261-271.
4. Coffelt S.B., Kersten K., Doornebal C.W., Weiden J., Vrijland K., Hau C.S., Verstegen N.J., Ciampricotti M., Hawinkels L.J., Jonkers J., de Visser K.E. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015, 522:345-348.
5. Croker B.A., Metcalf D., Robb L., Wei W., Mifsud S., DiRago L., Cluse L.A., Sutherland K.D., Hartley L., Williams E., et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004, 20:153-165.
6. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828.
7. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12:253-268.
8. Gerbal-Chaloin S., Iankova I., Maurel P., Daujat-Chavanieu M. Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metab. Rev. 2013, 45:122-144.
9. Gordy C., Pua H., Sempowski G.D., He Y.W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 2011, 117:618-629.
10. Goren I., Allmann N., Yogev N., Schürmann C., Linke A., Holdener M., Waisman A., Pfeilschifter J., Frank S. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am. J. Pathol. 2009, 175:132-147.
11. Gray E.E., Suzuki K., Cyster J.G. Cutting edge: Identification of a motile IL-17-producing gammadelta T cell population in the dermis. J. Immunol. 2011, 186:6091-6095.
12. Guo R.F., Ward P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 2005, 23:821-852.
13. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 1992, 12:954-961.
14. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
15. Hirai H., Zhang P., Dayaram T., Hetherington C.J., Mizuno S., Imanishi J., Akashi K., Tenen D.G. C/EBPbeta is required for 'emergency' granulopoiesis. Nat. Immunol. 2006, 7:732-739.
16. Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 2002, 14:798-802.
17. Hueber A.J., Asquith D.L., Miller A.M., Reilly J., Kerr S., Leipe J., Melendez A.J., McInnes I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 2010, 184:3336-3340.
18. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
19. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
20. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
21. Jin F., Li Y., Ren B., Natarajan R. PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc. Natl. Acad. Sci. USA 2011, 108:5290-5295.
22. Kojetin D.J., Burris T.P. REV-ERB and ROR nuclear receptors as drug targets. Nat. Rev. Drug Discov. 2014, 13:197-216.
23. Kreisel D., Sugimoto S., Tietjens J., Zhu J., Yamamoto S., Krupnick A.S., Carmody R.J., Gelman A.E. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J. Clin. Invest. 2011, 121:265-276.
24. Larghi P., Porta C., Riboldi E., Totaro M.G., Carraro L., Orabona C., Sica A. The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity. PLoS ONE 2012, 7:e45279.
25. Liu B., Tan W., Barsoum A., Gu X., Chen K., Huang W., Ramsay A., Kolls J.K., Schwarzenberger P. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement. Exp. Hematol. 2010, 38:877-884.e1.
26. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 2010, 22:231-237.
27. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
28. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
29. Metcalf D. Hematopoietic cytokines. Blood 2008, 111:485-491.
30. Moalli F., Doni A., Deban L., Zelante T., Zagarella S., Bottazzi B., Romani L., Mantovani A., Garlanda C. Role of complement and Fcgamma receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010, 116:5170-5180.
31. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238-244.
32. Porta C., Rimoldi M., Raes G., Brys L., Ghezzi P., Di Liberto D., Dieli F., Ghisletti S., Natoli G., De Baetselier P., et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. USA 2009, 106:14978-14983.
33. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
34. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., Nussenblatt R.B., Caspi R.R. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 2008, 180:5167-5171.
35. Ries C.H., Cannarile M.A., Hoves S., Benz J., Wartha K., Runza V., Rey-Giraud F., Pradel L.P., Feuerhake F., Klaman I., et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 2014, 25:846-859.
36. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., Di Santo J.P., Eberl G. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010, 330:665-669.
37. Schwarzenberger P., Huang W., Ye P., Oliver P., Manuel M., Zhang Z., Bagby G., Nelson S., Kolls J.K. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 2000, 164:4783-4789.
38. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 2007, 117:1155-1166.
39. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., van Damme J., Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 2000, 164:762-767.
40. Sinha P., Chornoguz O., Clements V.K., Artemenko K.A., Zubarev R.A., Ostrand-Rosenberg S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 2011, 117:5381-5390.
41. Stutman O. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 1974, 183:534-536.
42. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., Mebius R.E., Littman D.R. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288:2369-2373.
43. Taylor P.R., Roy S., Leal S.M., Sun Y., Howell S.J., Cobb B.A., Li X., Pearlman E. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat. Immunol. 2014, 15:143-151.
44. Toomer K.H., Chen Z. Autoimmunity as a double agent in tumor killing and cancer promotion. Front. Immunol. 2014, 5:116.
45. Torroella-Kouri M., Silvera R., Rodriguez D., Caso R., Shatry A., Opiela S., Ilkovitch D., Schwendener R.A., Iragavarapu-Charyulu V., Cardentey Y., et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 2009, 69:4800-4809.
46. Tripodo C., Sangaletti S., Guarnotta C., Piccaluga P.P., Cacciatore M., Giuliano M., Franco G., Chiodoni C., Sciandra M., Miotti S., et al. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. Blood 2012, 120:3541-3554.
47. Ueha S., Shand F.H., Matsushima K. Myeloid cell population dynamics in healthy and tumor-bearing mice. Int. Immunopharmacol. 2011, 11:783-788.
48. Ulich T.R., del Castillo J., Souza L. Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am. J. Pathol. 1988, 133:630-638.
49. Winkler I.G., Sims N.A., Pettit A.R., Barbier V., Nowlan B., Helwani F., Poulton I.J., van Rooijen N., Alexander K.A., Raggatt L.J., Lévesque J.P. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
50. Wittke A., Weaver V., Mahon B.D., August A., Cantorna M.T. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 2004, 173:3432-3436.
51. Wu P., Wu D., Ni C., Ye J., Chen W., Hu G., Wang Z., Wang C., Zhang Z., Xia W., et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014, 40:785-800.
52. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
53. Zamarron B.F., Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int. J. Biol. Sci. 2011, 7:651-658.
54. Zhang H., Nguyen-Jackson H., Panopoulos A.D., Li H.S., Murray P.J., Watowich S.S. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 2010, 116:2462-2471.
55. Zhu X., Mulcahy L.A., Mohammed R.A., Lee A.H., Franks H.A., Kilpatrick L., Yilmazer A., Paish E.C., Ellis I.O., Patel P.M., Jackson A.M. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 2008, 10:R95.
56. Zhuang Y., Peng L.S., Zhao Y.L., Shi Y., Mao X.H., Chen W., Pang K.C., Liu X.F., Liu T., Zhang J.Y., et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012, 143:951-962.e8.